PFIZER JAPAN OBTAINS APPROVAL FOR GENOTROPIN TREATMENT FOR ADULT GROWTH HORMONE DEFICIENCY

Pfizer Japan Inc. has received the approval of Genotropin for Adult Growth Hormone Deficiency patients (aGHD). Genotropin is considered the top drug in this market and has been certified in 66 countries worldwide. JCN Network (http://www.japancorp.net/Article.Asp?Art_ID=12991)